Orchard Therapeutics (London) 別ウィンドウで開く
Gene therapy development
Ex vivo autologous gene therapy
Treatment of adenosine deaminase severe combined immunodeficiency (ADA‑SCID)
Treatment of mucopolysaccharidosis type IIIA (MPS‑IIIA)
London, United Kingdom
会社名
Group
親会社
子会社
得意先
仕入先
銀行等
株主等
2026-03-12 20:19 (Model: gpt-oss:20b )